Skip to main content

Frequency, types, and factors associated with complementary and alternative medicine use among patients on maintenance haemodialysis

Abstract

Background

Despite progress in haemodialysis and conventional medicine approaches, many patients still struggle to maintain an acceptable quality of life and turn to complementary and alternative medicine (CAM) to address their unmet needs.

Objective

This study aims to determine the prevalence, types, indications, and factors associated with CAM use by patients on maintenance haemodialysis (MHD) in Cameroon.

Materials and methods

This was a multicentric cross-sectional study involving MHD patients in Cameroon from February 2019 to May 2019. We included all consenting participants on MHD for at least 3 months and excluded participants with cognitive and behavioral problems. Face-to-face interviews were conducted.

Results

A total of 224 participants (145 males) with a mean age of 56.5 ± 14.2 years and a median haemodialysis vintage of 34.5 [IQR: 17.3–64.4] months were recruited. In all, 89.7% (n = 201) reported having used CAM before, while 71.6% (n = 144) were still using it. Biologically based therapies were the most popular (94%, n = 189), with herbal medicine (81.5%, n = 154) and Calabar chalk (52.4%, n = 99) being the most common. Physical well-being (57.2%), nausea (52%), and insomnia (42.7%) were the main indications for CAM use. Most respondents did not disclose their CAM use to their physicians (61.2%). Long haemodialysis vintage was associated with CAM use (AOR: 7.9; CI = 2.8–22.3; p < 0.001).

Conclusions

The use of CAM is common among Cameroon’s haemodialysis population, with herbal medicines and Calabar chalk being the most frequent. The high symptom burden makes CAM attractive to them. Healthcare teams should be aware of these practices, initiate an open discussion, and appropriately advise patients about dangers, risks, and safety associated with their use.

Trial registration

The institutional review board of the University of Bamenda. Reference: 2019/0038H/UBa/IRB UPM/TNCPI/RMC/1.4.18.2.

Peer Review reports

Introduction

Chronic kidney disease is a major global health problem [1]. In advanced cases, it is associated with high mortality and morbidity, poor quality of life, and high resource utilization and cost of care [2]. Despite significant medical advances over several decades in the management of end-stage kidney failure (ESKF), these patients still face a multitude of physical and emotional symptoms and exhibit substantial impairment in quality of lif e[3]. To control and cope with their symptoms and improve their quality of life, many turn to complementary and alternative medicine (CAM). However, the use of CAM among this subpopulation is of great concern, as biologically based therapies which are the most widely used CAM modalities worldwide, seem to pose a greater risk to this population than to the general population [4]. This is mainly due to the poor excretory function that could alter pharmacokinetics and pharmacodynamics leading to increased toxicity, a greater chance of drug interactions, and potentially lethal electrolyte abnormalities [5].

CAM is defined as any medical and health care systems, practices, or products that are not thought of as standard medical care [6]. There is increasing use of CAM worldwide particularly in low- and middle-income countries, with claims of its benefits and non-nocive nature compared to conventional medicine [4]. The reported global prevalence of CAM use in the general population ranges from 10 to 94% with wide variation due to factors such as differences in the population characteristics, response rates, CAM definitions used, and study methodology. In European countries, the prevalence ranges between 10 and 40% [7], 40–60% in the USA [8], 63.1% in Australia [9], 62.5%.in Saudi Arabia [10] and 4.6–94% in sub-Saharan Africa [11]. In Cameroon, 80% of the population uses CAM mostly based on plants [12].

Data on this practice among the ESKF population worldwide remain scarce possibly because many patients who use CAM withhold this information from their primary healthcare team [13]. Previous worldwide studies revealed a prevalence of CAM use among haemodialysis patients ranging between 18.8 and 67% [14,15,16,17,18,19,20]. The modalities and sources of these forms of CAM vary around the world depending on cultural or traditional beliefs. The aim of this study was to determine the prevalence, modalities, and factors associated with CAM use among maintenance haemodialysis patients in Cameroon.

Materials and methods

Study design and setting

This multicentric cross-sectional study was conducted over a period of 4 months from February 2019 to May 2019 in Cameroon. Three state-owned haemodialysis centres were selected (convenience): the Yaounde General Hospital (YGH), Bamenda Regional Hospital (BaRH), and the Buea Regional Hospital (BRH) haemodialysis centres. The Bamenda and Buea regional hospitals are second-level hospitals located in the North and South West regions of the country, respectively, whereas the Yaounde General Hospital is a fourth-level hospital located in the capital city of Cameroon, precisely in the Center region. All three facilities are government funded and offer a twice-weekly dialysis program of 8 h per week. The 3 centers are all managed by nephrologists.

In Cameroon, out-of-pocket payments account for the majority of health-care financing. Since 2002, the government has subsidized haemodialysis sessions in public-sector centres. Patients are charged XAF 5000 ($ 7.79) per haemodialysis session. This price excludes the costs of vascular access, laboratory tests, medication, feeding, transportation, hospitalization, and vaccination. All of these extra expenditures are borne by patients and their families.

Study participants and procedure

We included consenting participants on maintenance hemodialysis (MHD) for at least 3 months and excluded patients with cognitive impairment or cancer and those unable to communicate verbally or to complete the interview. Patients were met on the day of their dialysis and at the dialysis center. Face-to-face interviews using a questionnaire were conducted either during the haemodialysis session or in the waiting room.

Sample size calculation

Sampling was consecutive and exhaustive. The sample size estimation was based on Bahall’s prevalence in Trinidad [14], and the online Sample Size Calculator software was used. The minimum sample required was n = 167 to have a confidence level of 90% and a margin of error of 5% of the surveyed value.

Questionnaire

A prestructure questionnaire was designed for this study. This questionnaire contains 2 main sections: a sociodemographic and clinical section and a section on CAM use. The patient’s case file was used to complete the section pertaining to the sociodemographic and clinical information. For the cultural area of origin, participants specified whether they were from grassfield (found in the northwestern and western regions), soudano-Sahel (found in the Far-North, North and Adamawa regions), coastal (found in the littoral and southwestern regions), forest (found in the Central and southern regions) backgrounds or nonnationals. Other sociodemographic and clinical information collected included age, gender (male and female), religion (Christian, Muslim, atheist, and other), marital status (single, married, divorced, and widowed), level of formal education (none, primary, secondary and tertiary), comorbidities, aetiology of ESKF, actual treatment and duration of haemodialysis. For the use of CAM, we were interested in the nature and forms of CAM used, the sources of information and procurement, the reason for utilization, and disclosure of CAM use to the treating physician.

Variables

Independent variables were sociodemographic characteristics (age, sex, marital and educational status), the presence of comorbidities, aetiologies of ESKF, duration of haemodialysis, use of CAM, modalities of CAM used, reasons for CAM use, and disclosure of CAM use to the treating physician. Dependent variables were the prevalence of CAM use, and factors associated with CAM use among haemodialysis patients.

Data collection

The data on patient sociodemographics and disease-related information were collected from the patient’s case files, while the knowledge of CAM and its use by the participants were assessed using a face-to-face interview. All cases were identified by the code number. The information collected was based on the PROFORMA checklist. These data were entered into the Census Survey Processus (CSPro version 7.2) system.

Data analysis

Data entered into the CSPro version 7.2 system were exported to the Statistical Package for Social Sciences (SPSS) version 23.0 software for statistical analysis (descriptive and inferential analysis). The descriptive methods included frequency distribution, tables, and graphs. Binary logistic regression was used to identify the predictors of CAM use in the study population based on significant associations identified from sociodemographic variables. All hypotheses were tested at the 5% level of significance. Analysed data are presented as odds ratios (ORs), 95% confidence intervals (95% CIs), and p-values. For multiple logistic regression, only variables with p-values < 0.20 or any clinically significant factor were selected for multiple logistic regression analysis.

Definition of terms

Complementary and alternative medicine (CAM) was defined as any health-related practice that was not prescribed by a medical doctor and not considered conventional medicine.

The modalities of CAM therapies are classified into four categories as in Zakaria et al’s study [4]. These are divided into biologically based therapies, manipulative body-based therapies, mind-body interventions, and alternative medical systems. Biologically based therapies included plants and plant extracts (garlic, ginseng, aloe vera, moringa, green tea, ginger, guava leaves,etc.), geophagic naturally occurring minerals (Calabar chalk), dietary supplements (vitamins B and D) and animal-derived products (honey, eggs). Herbs are defined as any plant part that is used as medicine in any form (leaves, stems, roots, herbal teas, fruits except fruit juices). We are considered as manipulative and body-based therapies, the scarification and massage. Meditation, prayer, fasting, anointed water/oil/bracelets/stickers/cross, sacrifices, music therapy, holy water, exorcism, and burning of incense were considered mind and body interventions. We defined music therapy as regular, intentional listening to music for relaxation and general well-being. We considered as folk/indigenous medicine, the magic, divination, and sacrifices to deities done for health purposes. The level of education was divided into 4 categories: none (for those who had never been to school), primary (for those who interrupted their primary schooling), secondary (for those who interrupted their secondary schooling) and tertiary (for those with university studies).

Results

A total of 296 patients were approached. Among these patients, 72 were excluded, 27 patients for a haemodialysis vintage of fewer than 3 months, 27 patients for no consent, 15 for an incomplete interview, 2 patients had cognitive impairment, and 1 was deaf-and-dumb (see Fig. 1). A total of 224 participants were thus interviewed (145 males), with a mean age ± SD of 56.5 ± 14.2 years and a median haemodialysis vintage of 34.5 [17.4–64.4] months. Most of the participants were from grassfields (54.0%), Christians (93.3%), married (61.2%; n = 137) and had received secondary education (77.2%; n = 173). A total of 105 (48.8%) participants were from the YGH, 61 (27.2%) from the BRH, and 58 (25.8%) from the BaRH. Table 1 summarizes the sociodemographic data. The main comorbidities of the participants were hypertension (83.9%; n = 188), diabetes mellitus (13.4%; n = 30) and HIV (8.9%; n = 20). The comorbidities and aetiologies of ESKF of the respondents are outlined in Table 2.

Fig. 1
figure 1

Recruitment flow chart. YGH: Yaounde General Hospital; BaRH: Bamenda Regional Hospital; BRH: Buea Regional Hospital

Table 1 Sociodemographic characteristics of participants (N = 224)
Table 2 Frequency of comorbidities, HD vintage, and etiology of ESKF according to dialysis centers(N = 224)

Concerning CAM use, 89.7% (n = 201) of the participants reported having used CAM for the treatment of ESKF-related symptoms, with 71.6% (n = 144) reporting use within a month of the survey. Among the four categories of CAM, biological-based therapies (94%, n = 189) and mind-body practice (82.1%, n = 165) were the most popular CAMs used (see Fig. 2). The biological-based therapies were dominated by herbal medicine (81.5%; n = 154), and Calabar chalk (52.4%; n = 99) (see Table 3). Calabar chalk, also known as calabar stone, is a geophagic mineral stone belonging to the kaolinite family made up of fossilized seashell clay material. The mean number of herbs used per participant was 3.7 ± 2.5. Over half of the participants (63%, n = 97) used more than 2 herbs. Garlic (35.3%) and beetroot (27.4%) were the most frequently used herbs (see Table 4). Christian spiritual healing was the most common form of mind-body practice in 93.3% (n = 209) of our community. Family members and friends (67%) and other patients (42.3%) were the main sources of information about CAM (see Table 5). Home/farm (61.7%, n = 124) and market/supermarket (61.2%, n = 123) were the main sources of procurement. Physical well-being (57.2%), nausea (52%), and insomnia (42.7%) were the main reasons for CAM use (see Table 6). The majority (61.2%; n = 123) of participants did not disclose their CAM usage to their treating physicians, mainly because they assumed their physician would disapprove (38.2%, n = 47) or that the physician did not believe in it (33.3%, n = 41) (see Fig. 3).

Fig. 2
figure 2

Number of CAM users based on the modalities of CAM use (some respondents with multiple responses)

Table 3 Types of biological-based therapy use (N = 189)
Table 4 Herbal medicine used by participants (N = 146)
Table 5 Distribution of participants according to the source of information about CAM (n = 201)
Table 6 Distribution of respondents by indication/reasons of CAM use (n = 201)
Fig. 3
figure 3

Reasons for nondisclosure of CAM use to treating physicians (N = 201)

Long haemodialysis vintage (AOR: 7.9; CI = 2.8–22.3; p < 0.001) was the only factor independently associated with CAM use (see Tables 7 and 8).

Table 7 Factors associated with CAM use (Bivariate analysis)
Table 8 Factors associated with CAM use (multivariate analysis) (n = 201)

Discussion

This multicentric cross-sectional study documents the prevalence and pattern of CAM use in a haemodialysis population in Cameroon. We observed that 89.7% of subjects used CAM. The majority (61.2%) did so without informing their treating physician. Biological-based therapy (94%, n = 189) was the most commonly used form of CAM, followed by mind-body practices (82.1%, n = 165). A long duration on haemodialysis (> 24 months) was an independent predictor of CAM use.

We found a higher prevalence of CAM use in this study, greater than those previously described worldwide [14,15,16,17,18,19,20]. This high prevalence of CAM use in our setting probably reflects the high prevalence of CAM use in the general population. Indeed, the prevalence of CAM use varies according to the cultural beliefs and practices of different populations [19]. Among the general population in Cameroon, the prevalence of CAM use was reported to be 80%, similar to our results [12]. Many factors may explain this high prevalence. The high symptom burden, escalating comorbid illnesses, progressive decline in clinical state and quality of life, and absence of implementation of patient-centred palliative care in our haemodialysis centres cause high frustration and a loss of trust in conventional medicine. In addition, the high cost of conventional medical treatment and the cultural belief in the safety and efficiency of CAM compared with conventional medicine make CAMs attractive for these populations [11, 21, 22]. It is therefore not surprising that patients turn to CAM lightly to meet their physical, psychological, and spiritual needs, which are often undertreated by their physicians.

We observed that most of the CAM use was undisclosed to the treating physician, as has been reported previously [19, 20, 23]. The reasons for this attitude include the assumption that their physician would disapprove of it (38.2%) or that the physician did not believe in it (33.3%). It is therefore crucial for nephrologists to inquire about such practices, which could interact with medications, affect adherence to conventional therapy, and could be harmful [23].

Biological-based therapy was the most common CAM used by the respondents, with herbal medicines and calabar chalk being the most frequent. These findings are consistent with those described in the general population in Cameroon and sub-Saharan Africa, describing herbal medicines as the most commonly used form of CAM [11]. However, because of the unpredictable pharmacokinetics of these herbal medicine constituents in renal failure, their use is not always safe in ESKF. Moreover, most of these biological-based therapies were homemade remedies obtained from farms (61.7%) and local markets (61.2%) and were guided by nonmedical family members, friends, or other patients. Although some herbal medicines may have evidence supporting their use, some have no reliable evidence, and others may be potentially harmful [23,24,25]. Garlic (Allium sativum: 35.3%) was the most common herbal product used by our participants. Several studies have confirmed its effectiveness in lowering blood lipids, glucose, systolic blood pressure, inflammatory biomarkers, and platelet activity [26,27,28]. However, garlic has also been shown to interact with antihypertensive medications such as calcium channel blockers, which are commonly used by these patients. Garlic also has antiplatelet and anticoagulant properties, which may increase the risk of bleeding, particularly in patients taking heparin or aspirin [26]. Another frequently used biological agent was calabar chalk, also known as calabar stone, which is a mineral stone belonging to the kaolinite family made up of fossilized seashell clay material but can be prepared artificially by molding and heating mixed clay, mud, sand, wood, and even salt [3]. Calabar chalk geophagia is used to counteract some uremic symptoms such as nausea, hyperkalaemia, and mouth odor. It has been reported to contain several poisonous substances such as lead, arsenic, aluminum, and alpha lindane [29]. Calabar chalk has also been linked to hepatic sinusoidal enlargement, gastrointestinal damage, bone demineralization, nervous and brain damage, and anaemic effects in animals and humans [30, 31]. In addition to the poisonous substances whose adverse effects have thus far been reported, calabar chalk contains kaolin, which coats the gastrointestinal tract. Kaolin adsorbs drugs and other substances, including toxins, which, in addition to reducing their bioavailability, initiate diarrhoeal episodes, thus providing bulk to the stool [31, 32].

Mind-body practices (82.1%, n = 165) were the second most common CAM modality used in all 3 haemodialysis centres and were used concomitantly with other CAMs in most cases. This high frequency of its use in our population contrasts with low rates (4 to 42%) reported in other communities [14, 15, 20]. However, this may be due to differences in the definition of mind-body interventions used and differences in familiarity with this CAM modality. Some studies have suggested that mind-body practices may be useful for patients with ESKF [15, 33,34,35]. Mind-body interventions such as prayer, relaxation, or exorcism often involve self-care-based actions that are not expensive, produce relaxing effects, and can bring about beneficial physiological, functional, and psychological changes in MHD patients. They have almost no adverse effects and only rarely interact with conventional treatment [13]. Christian spiritual healing was the most common form of mind-body practice, as 93.3% (n = 209) of our community was Christians.

We found that a long duration of MHD (HD vintage > 24 months) was independently associated with CAM use on multivariate analysis (OR = 7.9; p-value < 0.001). A similar finding was observed in India [13] but was not confirmed in the USA [15]. Patient frustration with the efficacy of conventional medicine and/or the cost frequently explains this attraction to the CAM.

Conclusion

The use of CAM is common among Cameroon’s haemodialysis population, with herbal medicines and Calabar chalk being the most frequent. The long haemodialysis vintage favours this practice. Many physicians are frequently not involved in the decision to use them. Healthcare teams should be aware of these practices, initiate an open discussion, and appropriately advise patients about the dangers and safety associated with their use.

Study limitations

This study has some limitations. Its cross-sectional design renders the result subject to recall bias regarding CAM use. However, this was an exhaustive review of the subjects in all 3 haemodialysis centres, and to our knowledge, this is the first study carried out in Cameroon examining the use of CAM among this subpopulation.

Availability of data and materials

The datasets used and/or analysed during the current study are available from https://zenodo.org/record/7217860#.Y03X_XbMLrc

Abbreviations

AOR:

Adjusted odds ratio

BaRH:

Bamenda regional hospital

BRH:

Buea Regional Hospital

CAM:

Complementary and alternative medicine

CGN:

Chronic glomerulonephritis

ESKF:

End stage kidney failure

MHD:

Maintenance haemodialysis

USA:

United States of America

YGH:

Yaounde General Hospital

References

  1. Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, et al. KDIGO 2021 clinical practice guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4):S1–276.

    Article  Google Scholar 

  2. Han Y, Saran R. Global Dialysis perspective: United States. Kidney360. 2020;1(10):1137–42.

    Article  Google Scholar 

  3. Ebana HDFM, Nkojap AK, Mapoure Y, Owona S, Bertr A, et al. Geochemistry and acute toxicity in rat of calabash clay consumed in Douala (Cameroon). Environmental & Analytical. Toxicology. 2021;11(6):1–4.

    Google Scholar 

  4. Zakaria NF, Mohd Noor MT, Abdullah R. Traditional and complementary medicine use among chronic haemodialysis patients: a nationwide cross-sectional study. BMC Complement Med Ther. 2021;21(1):1–12.

    Article  Google Scholar 

  5. Duncan H, Pittman S, Govil A, Sorn L, Bissler G, Schultz T, et al. Alternative medicine use in dialysis patients: potential for good and bad! Nephron Clin Pract. 2007;105(3):c108–13.

    Article  Google Scholar 

  6. National Cancer Institute at the National Institutes of Health. Complementary and alternative medicine for patients. Bethesda: USA National Cancer Institute; 2019. Available from: https://www.cancer.gov/about-cancer/treatment/cam/patient

    Google Scholar 

  7. Kemppainen L, Kemppainen T, Reippainen J, Salmenniemi S, Vuolanto P. Use of complementary and alternative medicine in Europe: health-related and sociodemographic determinants. Scand J Public Health. 2018;46(4):448–55.

    Article  Google Scholar 

  8. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl Health Stat Rep. 2015;79:1.

    Google Scholar 

  9. Steel A, McIntyre E, Harnett J, Foley H, Adams J, Sibbritt D, et al. Complementary medicine use in the Australian population: Results of a nationally-representative cross-sectional survey. Sci Rep. 2018;8(1):1–7.

    Article  Google Scholar 

  10. Aljawadi M, Khoja A, AlOtaibi A, Alharbi K, Alodayni M, AlMetwazi M, et al. The utilization of complementary and alternative medicine among Saudi older adults: a population-based study. Evid Based Complement Altern Med. 2020;2020:4357194.

    Article  Google Scholar 

  11. James P, Wardle J, Steel A, Adams J. Traditional, complementary and alternative medicine use in sub-Saharan Africa: a systematic review. BMJ Glob Health. 2018;3(5):e000895.

    Article  Google Scholar 

  12. Njamen D, Mvondo M, Djiogue S, Ketcha Wanda G, Magne Nde C, G V. Phytotherapy and women’s reproductive health: the Cameroonian perspective. Planta Med. 2013;79(7):600–11.

    Article  CAS  Google Scholar 

  13. Arjuna Rao A, Phaneendra D, Pavani C, Soundararajan P, Rani N, Thennarasu P, et al. Usage of complementary and alternative medicine among patients with chronic kidney disease on maintenance hemodialysis. J Pharm Bioallied Sci. 2016;8(1):52–7.

    Article  Google Scholar 

  14. Bahall M. Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: a descriptive study. BMC Complement Altern Med. 2017;17(1):250.

    Article  Google Scholar 

  15. Birdee GS, Phillips RS, Brown RS. Use of complementary and alternative medicine among patients with end-stage renal disease. Evid Based Complement Altern Med. 2013;2013:654109.

    Article  Google Scholar 

  16. Castelino LR, Nayak-Rao S, Shenoy MP. Prevalence of use of complementary and alternative medicine in chronic kidney disease: a cross-sectional single-center study from South India. Saudi J Kidney Dis Transpl. 2019;30(1):185–93.

    Article  Google Scholar 

  17. Kara B. Herbal product use in a sample of Turkish patients undergoing haemodialysis. J Clin Nurs. 2009;18(15):2197–205.

    Article  Google Scholar 

  18. Nowack R, Ballé C, Birnkammer F, Koch W, Sessler R, Birck R. Complementary and alternative medications consumed by renal patients in southern Germany. J Renal Nutr. 2009;19(3):211–9.

    Article  Google Scholar 

  19. Zakaria NF, Mohd Noor MT, Abdullah R. Traditional and complementary medicine use among chronic haemodialysis patients: a nationwide cross-sectional study. BMC Complement MedTher. 2021;21(1):94.

    Article  Google Scholar 

  20. Zyoud SH, Al-Jabi SW, Sweileh WM, Tabeeb GH, Ayaseh NA, Sawafta MN, et al. Use of complementary and alternative medicines in haemodialysis patients: a cross-sectional study from Palestine. BMC Complement Altern Med. 2016;16(1):204.

    Article  Google Scholar 

  21. Schmidt RJ. Incorporating supportive care into the hemodialysis unit. Curr Opin Nephrol Hypertens. 2017;26(6):530–6.

    Article  Google Scholar 

  22. Murtagh F, Burns A, Moranne O, Morton R, Naicker S. Supportive care: comprehensive conservative Care in end-Stage Kidney Disease. Clin J Am Soc Nephrol. 2016;11(10):1909–14.

    Article  Google Scholar 

  23. Osman NA, Hassanein SM, Leil MM, NasrAllah MM. Complementary and alternative medicine use among patients with chronic kidney disease and kidney transplant recipients. J Ren Nutr. 2015;25(6):466–71.

    Article  Google Scholar 

  24. Dahl N. Herbs and supplements in dialysis patients: panacea or poison? Semin Dial. 2001;14(3):186–92.

    Article  CAS  Google Scholar 

  25. Jha V. Herbal medicines and chronic kidney disease. Nephrology (Carlton, Vic). 2010;2(SUPPL. 2):10–7.

    Article  Google Scholar 

  26. Cavagnaro P, Camargo A, Galmarini C, Simon P. Effect of cooking on garlic (Allium sativum L.) antiplatelet activity and thiosulfinates content. J Agric Food Chem. 2007;55(4):1280–8.

    Article  CAS  Google Scholar 

  27. Zare E, Alirezaei A, Bakhtiyari M, Mansouri A. Evaluating the effect of garlic extract on serum inflammatory markers of peritoneal dialysis patients: a randomized double-blind clinical trial study. BMC Nephrol. 2019;20(1):26.

    Article  Google Scholar 

  28. Ribeiro M, Alvarenga L, Cardozo LFMF, Chermut TR, Sequeira J, de Souza Gouveia Moreira L, et al. From the distinctive smell to therapeutic effects: garlic for cardiovascular, hepatic, gut, diabetes and chronic kidney disease. Clin Nutr. 2021;40(7):4807–19.

    Article  CAS  Google Scholar 

  29. Dean J, Deary M, Gbefa B, Scott W. Characterization and analysis of persistent organic pollutants and major, minor and trace elements in calabash chalk. Chemosphere. 2004;57(1):21–5.

    Article  CAS  Google Scholar 

  30. Ekong M, Peter A, Ekanem T, Eluwa M, Mbadugha C, Osim E. Calabash Chalk’s Geophagy affects gestating rats’ behavior and the Histomorphology of the cerebral cortex. Int J Brain Sci. 2014;2014:1–8.

    Article  Google Scholar 

  31. Ekong M, John E, Mbadugha CC, Bassey EI, Ekanem TB. Effect of calabash chalk on the Histomorphology of the gastro-Oesophageal tract of growing Wistar rats. Malaysian J Med Sci. 2012;19(1):30.

    Google Scholar 

  32. Onyekweli A, Usifoh C, Okunrobo L, Zuofa J. Adsorptive property of kaolin in some drug formulations. 2003;2(1):155 ajol.info.

  33. Mustata S, Cooper L. The effect of a tai chi exercise program on quality of life in patients on peritoneal dialysis: a pilot study. Perit Dial Int. 2005;25:291–4 journals.sagepub.com.

    Article  Google Scholar 

  34. Sutinah S, Azhari R. The effects of relaxation breathing on fatigue in patients with chronic kidney disease undergoing hemodialysis. Malahayati Int J Nurs Health Sci. 2020;3(1):15–21.

    Google Scholar 

  35. Yurtkuran M, Alp A, Yurtkuran M, Dilek K. A modified yoga-based exercise program in hemodialysis patients: a randomized controlled study. Complement Ther Med. 2007;15(3):164–71.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are extremely grateful to the patients and their caregivers who agreed to participate in this study and the nurses for assisting with the care of the patients.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

ATM and GEA designed the study; GUE, ATM, DGT and MM collected the data and performed data analysis; ATM and GEA wrote the manuscript. All the authors read and approved the final version for publication.

Authors’ information

Alex Tatang Mambap (ATM): Assistant lecturer of Nephrology; Bamenda Regional Hospital, Bamenda, Cameroon; Department of Clinical Sciences, Faculty of Health Sciences, The University of Bamenda, Bamenda, Cameroon.

Gwendoline Enda Ukum (GEU): Medical Doctor; Department of Clinical Sciences, Faculty of Health Sciences, The University of Bamenda, Bamenda, Cameroon.

Denis G. Teuwafeu (DGT): Lecturer of Nephrology; Buea Regional Hospital, Bamenda, Cameroon; Department of Internal Medicine and Paediatrics, Faculty of Health Sciences, The University of Buea, Buea, Cameroon.

Mahamat Maimouna (MM): Assistant lecturer of Nephrology; Yaounde General Hospital, Yaounde, Cameroon; Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Cameroon;

Gloria Enow Ashuntantang (GEA): Professor of Nephrology; Yaounde General Hospital, Yaounde, Cameroon; Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Cameroon; Dean, Faculty of Health Sciences, The University of Bamenda, Bamenda, Cameroon.

Corresponding author

Correspondence to Alex Tatang Mambap.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Institutional Review Board (IRB) of the Faculty of Health Sciences of the University of Bamenda with reference number 2019/0038H/UBa/IRB UPM/TNCPI/RMC/1.4.18.2. Administrative authorizations were obtained from the directors of the Yaounde General Hospital (YGH), Bamenda Regional Hospital (BaRH), and Buea Regional Hospital (BRH). The study was conducted following the Declaration of Helsinki, and all participants provided written informed consent before enrolment.

Consent for publication

Not applicable.

Competing interests

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mambap, A.T., Ukum, G.E., Teuwafeu, D.G. et al. Frequency, types, and factors associated with complementary and alternative medicine use among patients on maintenance haemodialysis. BMC Complement Med Ther 22, 325 (2022). https://doi.org/10.1186/s12906-022-03815-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-022-03815-7

Keywords

  • Complementary and alternative medicine (CAM)
  • Haemodialysis
  • Prevalence
  • Cameroon